Johnson & Johnson (JNJ) reported Q4 FY 2019 earnings of $1.88 per share (versus $1.97 per share in Q4 FY 2018), beating analysts' consensus estimate of $1.87 per share.
The company's quarterly revenues amounted to $20.747 bln (+1.7% y/y), roughly in line with analysts' consensus estimate of $20.825 bln.
The company also issued guidance for FY 2020, projecting EPS of $8.95-9.10 versus analysts' consensus estimate of $9.09 and revenues of +4.5-5.5% y/y to $85.8-86.2 bln versus analysts' consensus estimate of $85.52 bln.
JNJ fell to $147.94 (-0.89%) in pre-market trading.